SynCardia wins FDA nod for destination therapy trial

SynCardia gains the FDA's O.K. to test its artificial heart as a permanent implant in 19 patients.

SynCardia plans to test its artificial heart as a permanent implant rather than a placeholder for donor transplants in 19 patients.

Food & Drug Administration (FDA), SynCardia

News Well, Clinical Trials, Cardiac Implants, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zU1lr1